Résumé IA
Réflexion en cours
Réflexion en cours
Nous avons examiné 10,000 résultats en direct pour multi cancer early detection and liquid biopsy et retenu les 3 options qui semblent les plus utiles à comparer en premier.
options sont SPOT-MAS Multi-Cancer Early Detection, Multi-Cancer Early Detection and Liquid Biopsy, et RISE Institute Multi-Cancer Early Detection (MCED) Evaluation.
Source: The Medical City
Description
A liquid biopsy genomic test designed for the early detection of multiple cancer types, offered through a partnership with Gene Solutions at the TMC NGS facility.
Idéal pour
Early cancer detection, Liquid biopsy screening, High Risk individuals et Preventive healthcare
Évaluation
Source: Lucence
Description
Proprietary genomic sequencing technology for detecting cancer signals early and guiding therapeutic selection via non-invasive blood tests.
Idéal pour
Early cancer screening, Treatment selection, Liquid biopsy diagnostics et Personalized oncology
Évaluation
Source: National Cancer Centre Singapore (NCCS)
Description
The RISE institute at NCCS evaluates and implements Multi-Cancer Early Detection (MCED) tests, which aim to screen for multiple cancer types simultaneously through advanced blood-based technology.
Idéal pour
Early cancer detection, Preventative screening, Multi Cancer blood tests et Research participants
Évaluation
| Comparer | #1SPOT-MAS Multi-Cancer Early Detection | #2Multi-Cancer Early Detection and Liquid Biopsy | #3RISE Institute Multi-Cancer Early Detection (MCED) Evaluation |
|---|---|---|---|
| Source | The Medical City | Lucence | National Cancer Centre Singapore (NCCS) |
| Description | A liquid biopsy genomic test designed for the early detection of multiple cancer types, offered through a partnership with Gene Solutions at the TMC NGS facility. | Proprietary genomic sequencing technology for detecting cancer signals early and guiding therapeutic selection via non-invasive blood tests. | The RISE institute at NCCS evaluates and implements Multi-Cancer Early Detection (MCED) tests, which aim to screen for multiple cancer types simultaneously through advanced blood-based technology. |
| Idéal pour | Early cancer detection, Liquid biopsy screening, High Risk individuals et Preventive healthcare | Early cancer screening, Treatment selection, Liquid biopsy diagnostics et Personalized oncology | Early cancer detection, Preventative screening, Multi Cancer blood tests et Research participants |
| Action | SPOT-MAS Multi-Cancer Early Detection | Multi-Cancer Early Detection and Liquid Biopsy | RISE Institute Multi-Cancer Early Detection (MCED) Evaluation |
| Évaluation |
"SPOT-MAS Multi-Cancer Early Detection de The Medical City."
Je l'ai choisi parce que TMC combines world-class clinical care with advanced genomic screening for early cancer detection in a hospital-based setting.
Note : TopFind fournit des informations de comparaison uniquement à des fins de recherche générale.